Capstone Asset Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | $15.8M | Buy |
223,599
+8,643
| +4% | +$612K | 0.44% | 43 |
|
|
2017
Q1 | $14.6M | Buy |
214,956
+13,100
| +6% | +$890K | 0.41% | 47 |
|
|
2016
Q4 | $14.5M | Buy |
201,856
+7,685
| +4% | +$550K | 0.41% | 46 |
|
|
2016
Q3 | $15.4M | Buy |
194,171
+70,492
| +57% | +$5.58M | 0.44% | 41 |
|
|
2016
Q2 | $10.3M | Sell |
123,679
-1,189
| -1% | -$99.2K | 0.31% | 66 |
|
|
2016
Q1 | $11.5M | Sell |
124,868
-943
| -0.7% | -$86.6K | 0.33% | 62 |
|
|
2015
Q4 | $12.7M | Buy |
125,811
+9,926
| +9% | +$1M | 0.37% | 52 |
|
|
2015
Q3 | $11.4M | Buy |
115,885
+5,181
| +5% | +$509K | 0.35% | 58 |
|
|
2015
Q2 | $13M | Buy |
110,704
+1,692
| +2% | +$198K | 0.37% | 55 |
|
|
2015
Q1 | $10.7M | Buy |
109,012
+1,322
| +1% | +$130K | 0.3% | 71 |
|
|
2014
Q4 | $10.2M | Buy |
107,690
+12,010
| +13% | +$1.13M | 0.29% | 78 |
|
|
2014
Q3 | $10.2M | Buy |
95,680
+1,010
| +1% | +$108K | 0.35% | 55 |
|
|
2014
Q2 | $7.85M | Sell |
94,670
-24,566
| -21% | -$2.04M | 0.25% | 88 |
|
|
2014
Q1 | $8.45M | Sell |
119,236
-18,950
| -14% | -$1.34M | 0.26% | 87 |
|
|
2013
Q4 | $10.4M | Sell |
138,186
-96,518
| -41% | -$7.25M | 0.3% | 61 |
|
|
2013
Q3 | $14.8M | Sell |
234,704
-65,109
| -22% | -$4.09M | 0.36% | 44 |
|
|
2013
Q2 | $15.4M | Buy |
+299,813
| New | +$15.4M | 0.4% | 37 |
|